COO Poetting’s €5.5 million BioNTech sell‑off sparks “liquidity, not loss” debate as shares rebound on pipeline buzz.
BioNTech insider sale: COO Sierk Poetting sells 50k shares. Is this a sign of declining confidence? Learn what the move means for investors and the company’s growth prospects.
2 minutes to read